http://www.otcfn.com/ OTC Financial Network, a division of National Financial Communications Corp., is a full-service financial communications and investor relations firm that specializes in emerging, micro/small-cap companies.
http://www.otcgsw.com/ OTC Growth Stock Watch reports on companies with a market capitalization under $100 million dollars, which meet a set of Publisher and Chief Analyst Geoffrey Eiten’s rigid performance criteria: minimum 2-to-1 current ratio, minimal or no long-term debt, niche-oriented products and services, and an annual growth rate of over 20%.
I cannot speak to the BSTOR story, but if you look at the otcfn website you will see they have IR services including IR Services... Short and Long-term Consulting; Web-enabled CEO Reports on Audio and Corporate Streaming Videos; Email Blasts; Live and Archived Conference Calls; Investor Facts Reports.
Companies pay NFN for IR services. They do not shamelessly promote bad companies, but companies can fail. I know they worked with CLN...probably long before the FDA approval and the stock selloff..
As regards the OTC Growth Stock Watch...this is a long running monthly newsletter that updates subscribers about companies in the portfolio, why companies are deleted, and news blurbs about companies in the portfolio, and a featured new company each month for addition to the portfolio. I was sent the most recent issue after the LLLI promotion after speaking with Geoff. I am not a subscriber.
The OTC FN reviews lots of companies for publication of "Special Situations Report". Eiten does review the copy before publication. The purpose of these reports is to highlight promising companies with a splash for the purpose of adding to his subscription base. These companies do not rate OTC Growth Stock recognition according to the above criteria.
hope this helps...The OTC FN has been around a long time.. They must be doing some things right, but I have no "proof"
Market Data 
Markets 
AI
